MRSN
Mersana Therapeutics Inc

2,803
Loading...
Loading...
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
102

Frequently Asked Questions

What is Market Cap of Mersana Therapeutics Inc?
What is the 52-week high for Mersana Therapeutics Inc?
What is the 52-week low for Mersana Therapeutics Inc?
What is Mersana Therapeutics Inc stock price today?
What was Mersana Therapeutics Inc stock price yesterday?
What is the PE ratio of Mersana Therapeutics Inc?
What is the Price-to-Book ratio of Mersana Therapeutics Inc?
What is the 50-day moving average of Mersana Therapeutics Inc?
How many employess does Mersana Therapeutics Inc has?

Latest MRSN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.